Searched for
ASTRAZENECA PHARMA RESULTS
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...- AstraZeneca drug lowers high blood pressure in late-stage studyAstraZeneca's baxdrostat demonstrated significant blood pressure reduction in a late-stage trial for treatment-resistant hypertension, boos...
- AstraZeneca Pharma Q2 Results: Net profit falls 27% to Rs 38 croreAstraZeneca Pharma India on Wednesday said its net profit declined by 27 per cent on-year to Rs 38 crore in the second quarter ended on Sep...
- AstraZeneca Pharma gains despite fall in Q2 profit; here's whyIn the July-September quarter, AstraZeneca Pharma India reported a decline of 54.65 per cent in net profit to Rs 11.94 crore. In the same p...
- AstraZeneca Pharma India Q2 results: Net profit declines 55% to Rs 12 crIts revenue from operations during July-September 2021 stood at Rs 197.70 crore. It was Rs 209.47 crore for the same period a year ago, it ...
- AstraZeneca India Q1 results: Net profit declines 45% to Rs 10 crRevenue from operations stood at Rs 175.40 crore for the quarter under consideration. It was Rs 193.57 crore for the same period a year ago...
- AstraZeneca Pharma India Q3 results: Net profit declines 21% to Rs 21 crRevenue from operations of the company stood at Rs 200.25 crore for the quarter under consideration. It was Rs 223.86 crore for the same pe...
- Taking the good with the bad: How potential Covid-19 vaccines offered hope and disappointmentThis week the trial results on a few treatment options offered hope and disappointment. Vaccine developers also gave a realistic launch dea...
- Serum Institute of India seeks DCGI permission for phase 2/3 clinical trials of Oxford's COVID 'vaccine'The sources told that the Pune-based drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials...
- COVID-19: Infections rise, so do vaccine trialsEver since the Covid-19 outbreak late last year, the world has been moving much faster with regards to working on a vaccine and a possible ...
- AstraZeneca ‘On Track’ to roll out vaccine in September“We’re manufacturing indeed at risk — and that’s the only way to have the vaccine ready to go if it works,” he added. Oxford University beg...
- Board Meetings Today: Vedanta, Bharti Airtel, Torrent Pharma, Delta Corp and GSK PharmaAstrazeneca Pharma, Dr Lal Pathlabs and Monnet Ispat are among a few companies which will announce their March quarter results on Monday.
- AstraZeneca Pharma Q4 profit jumps threefold to Rs 10 croreTotal income stood at Rs 196.31 crore in the quarter, compared with Rs 153.06 crore a year ago.
- AstraZeneca gets marketing nod for asthma drug SymbicortResults from AstraZeneca's two clinical studies have shown that the addition of formoterol to budesonide improved asthma symptoms and lung ...
- AstraZeneca Pharma India Q4 net loss at Rs 2.87 croreThe company's total income from operations stood at Rs 111.57 crore for the quarter under consideration. It was Rs 158.82 crore for the sam...
- AstraZeneca Pharma Q3 net up 84 pc to Rs 16 croreThe company had reported a net profit of Rs 8.67 crore in October-December quarter a year ago, AstraZeneca Pharma said
- Dr Reddy’s pain may bring gains for Torrent & CiplaThe drug in focus is the generic version of Nexium, a heartburn pill, which has earned over $5.5 billion for the owner AstraZeneca so far.
- AstraZeneca Pharma surges on strong Q4 resultsAstraZeneca Pharma surged over 18% on Thursday on the back of strong results for the quarter ended March 2015.
- AstraZeneca Pharma Q4 net profit at Rs 38 croreNet sales stood at Rs 120.80 crore during the quarter, while the same were at Rs 114.14 crore during the same period in the previous fiscal.
- Astrazeneca Pharma Q3 net loss at Rs 18 croreAstrazeneca Pharma today posted a net loss of Rs 17.69 crore for its third quarter ended December 31, 2012.
Load More
